This report provides exclusive insights into the COVID-19 impact on the Neuropathic Pain Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Neuropathic Pain Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Neuropathic Pain Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on
neuropathic pain market provides an in-depth analysis of segments and sub-segments
in the global as well as regional neuropathic pain market. The study also
highlights the impact of drivers, restraints, and macro indicators on the
global and regional neuropathic pain market over the short term as well as long
term. The report is a comprehensive presentation of trends, forecast and dollar
values of global neuropathic pain market. According to the report, the global
neuropathic pain market is projected to grow at a CAGR of 6.1% over the
forecast period of 2019-2025.
The increasing occurrence of diabetes and cancer are the major
drivers for the growth of the neuropathic pain market across the globe.
Diabetes is the most common indication for neuropathic pain followed by cancer.
According to the International federation diabetes federation, nearly 420
million adult population were suffering from diabetes in 2016, and it is
increasing at a rate of 8.4% and is expected to reach 625 million by 2040.
Furthermore, the increase in the geriatric population also fuels the growth of
market growth. Furthermore, increasing awareness among patients for treatment
of neuropathic pain, a rise in the demand for generic drugs, and introduction
of new products for the treatment of neuropathic pain are some other factors
driving the growth of neuropathic pain market. However, severe side effects of
opioids and steroids and increasing prices of branded drugs are some of the
factors which may hamper the growth of the global neuropathic pain market.
Moreover, strong healthcare infrastructure and well-established reimbursements
create an opportunity for the growth of the global neuropathic pain market in
the next few years.
In terms of region, the global market for neuropathic pain has
been segmented into North America, Europe, Asia Pacific, and the Rest of the
World. North America holds the maximum market share and is expected to dominate
the neuropathic pain market during the forecast period. This is mainly due to a
strong distribution network and presence of advanced healthcare infrastructure
and major players in the market in the region. Furthermore, an increase in the
elderly population, which leads to too many disorders and diseases are some
other factors that help the growth of the market in the North American region.
The European market is estimated to be the second-largest over the forecast
period. This is attributed to the increasing cases of cancer patients in the
region. The Asia Pacific is estimated to grow at a beneficial rate due to the
growing occurrence of diabetes in countries such as China and India.
The report on global neuropathic pain market covers segments such
as type, indication, diagnosis, treatment, distribution channel, and end user.
On the basis of type, the sub-markets include phantom limb pain, trigeminal
neuralgia, post herpetic neuralgia, and post-traumatic neuropathy. On the basis
of indication, the sub-markets include spinal stenosis, and diabetic
neuropathy. On the basis of diagnosis, the sub-markets include imaging physical
examination, and blood tests. On the basis of treatment, the sub-markets include
medication type, NSAIDs type, antidepressant drugs type, and multimodal
therapy. On the basis of distribution channel, the sub-markets include retail
pharmacies and drug stores, and online pharmacies. On the basis of end user,
the sub-markets include hospitals, and clinics.
The report provides profiles of the companies in the market such
as Johnson & Johnson Services Inc., Pfizer Inc., Eli Lily and Company,
GlaxoSmithKline PLC, Bristol-Myers Squibb and Company, Sanofi S.A., Biogen Idec
Inc., Baxter Healthcare Corporation, and Depomed Inc.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of neuropathic
pain market. Moreover, the study highlights current market trends and provides
forecast from 2019-2025. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.